CompletedNot applicableNCT02276664
Official study title

Capitalizing on a Teachable Moment to Promote Smoking Cessation

Study summary

The purpose of this study is to develop and test a self-help smoking cessation treatment for patients receiving a lung cancer screening computed tomography (CT) scan.

Ask AI to explain this study
Start here

Key things to know

Main goalPrevention

This describes the study’s primary purpose.

What is being studiedSelf-Help (SHI) and Usual Care (UC)

The study team can explain what participation involves.

Who it may be forSmoking Cessation

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Aug 13, 2020 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?H. Lee Moffitt Cancer Center and Research Institute

Study sponsor

01
Study overview

What this study is about

Purpose
Prevention
Study type
Interventional
Phase
Not applicable
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Interventions being studied
Behavioral: Self-Help (SHI); Behavioral: Usual Care (UC)
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Study 1
  • Participants for Study I will be drawn from a list of patients who have received a CT scan at the Moffitt Cancer Center
  • Smoked at least one cigarette per week prior to undergoing the CT scan
  • Able to speak and read English Study 2
  • Smoked at least one cigarette over the past week
  • Able to read English

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • H Lee Moffitt Cancer CenterTampa, Florida

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 13, 2020. Always confirm current availability with the study team.

View original record ↗